Publications by authors named "Davide Rapezzi"

Claim this Profile
E
Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi, Caterina Patti, Davide Rapezzi

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy.
Raffaella Origa, Barbara Gianesin, Antonietta Zappu, Anna Rita Denotti, Mary Ann Di Giorgio, Davide Rapezzi

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi, Andrea Rossi, Davide Rapezzi

Leuk Lymphoma· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Tiziano Barbui, Alessandra Carobbio, Valerio De Stefano, Alberto Alvarez-Larran, Arianna Ghirardi, Davide Rapezzi

Ann Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of Cardiovascular Risk in Patients with Polycythemia Vera.
Giulia Benevolo, Monia Marchetti, Remo Melchio, Eloise Beggiato, Chiara Sartori, Davide Rapezzi

Vasc Health Risk Manag· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis.
Francesco Mannelli, Francesca Crupi, Roberta Zanotti, Livio Pagano, Davide Rapezzi

Ther Adv Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Mario Tiribelli, Roberto Latagliata, Massimo Breccia, Isabella Capodanno, Maria Cristina Miggiano, Davide Rapezzi

Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
Tiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, Alessandra Carobbio, Arianna Ghirardi, Davide Rapezzi

NEJM Evid· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients.
Cinzia Borgogna, Riccardo Bruna, Gloria Griffante, Licia Martuscelli, Marco De Andrea, Davide Rapezzi

Br J Haematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous allergic reaction correlates with anti-erythropoietin antibodies in dialysis patient developing pure red cell aplasia.
Iuliana Badiu, Davide Diena, Giuseppe Guida, Carlo Ferrando, Davide Rapezzi

Clin Case Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Davide Rapezzi

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.
Cinzia Borgogna, Riccardo Bruna, Gloria Griffante, Licia Martuscelli, Marco De Andrea, Davide Rapezzi

Blood Cancer J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
Alessia Castellino, Elisa Santambrogio, Davide Rapezzi, Massimo Massaia

Medicina (Kaunas)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy.
Alessandro Maria Vannucchi, Andrea Mortara, Andrea D'Alessio, Mara Morelli, Alberto Tedeschi, Davide Rapezzi

J Clin Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
Tiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, Arianna Masciulli, Alessandra Carobbio, Davide Rapezzi

Lancet Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases.
Alessia Castellino, Simona Elba, Roberto Sorasio, Claudia Castellino, Margherita Bonferroni, Davide Rapezzi

Clin Case Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Simona Elba, Alessia Castellino, Roberto Soriasio, Claudia Castellino, Margherita Bonferroni, Davide Rapezzi

J Med Case Rep· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second cancers in MPN: Survival analysis from an international study.
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Davide Rapezzi

Am J Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Valerio De Stefano, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Davide Rapezzi

Blood· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.
Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso, Francesco Albano, Mario Annunziata, Davide Rapezzi

Blood Adv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Carmen Fava, Giovanna Rege-Cambrin, Irene Dogliotti, Marco Cerrano, Paola Berchialla, Davide Rapezzi

Haematologica· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
Pier Paolo Piccaluga, Davide Rapezzi, Anna Gazzola, Michele Malagola, Giuseppe Visani

Bone Marrow Transplant· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi, Caterina Patti, Davide Rapezzi

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.
Valerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, Paola Guglielmelli, Alessandra Iurlo, Davide Rapezzi

Blood Cancer J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.
Massimo Breccia, Guendalina Graffigna, Sara Galimberti, Alessandra Iurlo, Ester Pungolino, Davide Rapezzi

Support Care Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis